• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE Back to Search Results
Model Number 7300TFX
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Endocarditis (1834); Insufficient Information (4580)
Event Date 12/15/2023
Event Type  Injury  
Event Description
It was learned through implant patient registry that a patient with a 29mm 7300tfx mitral valve was explanted after an implant duration of 4 months, 4 days due to unknown reason.The explanted valve was replaced with a 31mm 7300tfx valve.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was learned through implant patient registry and investigation that a patient with a 29mm 7300tfx mitral valve was medically treated for chlamydia pneumoniae infective endocarditis/vegetation with severe paravalvular regurgitation after implant duration of approximately 1 month.The valve was explanted after a implant duration of 4 months due to continued endocarditis and dehiscence.The valve was replaced with a 31mm 7300tfx valve.Per medical records, the patient presented with infective endocarditis, initial echo showed mitral valve rocking, small mobile mass on anterior/posterior leaflets consistent with vegetation, and severe pvl.History of iv drug abuse and noncompliance.The patient was discharged with 6 weeks of doxycycline for chlamydia pneumoniae.He was re-admitted approximately 2 months later, presented with exacerbation of chf and mitral valve was found to have dehisced.Consider non-compliance vs resistance as cause for increased titers.The patient underwent redo mvr with bovine pericardium patch reconstruction of the annulus.A 31mm 7300tfx was implanted and secured with cor-knots.The chest was left open due to coagulopathy, and he was transferred to the icu in stable condition.Per id doctor, completed a course iv ceftriaxone, continue on doxycycline po at least 6 months after cardiac surgery, consider lifelong therapy.The patient was discharged on pod #18.
 
Manufacturer Narrative
Per edwards microbiology report, chlamydia pnuemoniae organism is predominantly from respiratory infection and the sealed package containing this bioprosthetic valve was not the source of infection.H11 corrected data: based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2- office m2013
irvine, CA 92614
9492506615
MDR Report Key18681397
MDR Text Key335069470
Report Number2015691-2024-00916
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860057
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number7300TFX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/15/2024
Initial Date FDA Received02/09/2024
Supplement Dates Manufacturer Received02/23/2024
Supplement Dates FDA Received03/20/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient Age63 YR
Patient SexMale
-
-